The Artificial Tears market size is expected to reach $5.07 billion in 2030 at a CAGR of 6.3%, driven by rising prevalence of dry eye disease.
Read More
The Artificial Intelligence (AI) In Predictive Toxicology market size is expected to reach $2.29 billion in 2030 at a CAGR of 28.9%, driven by demand for efficient and ethical drug discovery.
Read More
The Artificial Intelligence (AI) In Biopharmaceuticals market size is expected to reach $8.77 billion in 2030 at a CAGR of 33.1%, driven by growing prevalence of chronic diseases.
Read More
The Arthritis Monoclonal Antibodies market size is expected to reach $98.46 billion in 2030 at a CAGR of 8.3%, driven by rising approvals for personalized medicines.
Read More
The Arthritic Therapeutic market size is expected to reach $97.09 billion in 2030 at a CAGR of 6.0%, driven by increasing incidence of arthritis.
Read More
The Artery Stenosis Drug market size is expected to reach $3.46 billion in 2030 at a CAGR of 5.9%, driven by growing prevalence of diabetes and obesity.
Read More
The Aripiprazole market size is expected to reach $11.12 billion in 2030 at a CAGR of 8.0%, driven by rising prevalence of psychiatric disorders.
Read More
The Aptamers market size is expected to reach $9.84 billion in 2030 at a CAGR of 24.8%, driven by increasing prevalence of chronic respiratory diseases.
Read More
The Zynyz market is witnessing steady growth over the forecast period, supported by increasing development of next-generation kinase inhibitors, rising demand for precision oncology treatments.
Read More
The Zynteglo market is witnessing steady growth over the forecast period, supported by increasing commercialization of gene editing therapies, rising investments in rare disease gene treatments.
Read More